cycloheximide has been researched along with Cancer of Ovary in 24 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (12.50) | 18.7374 |
| 1990's | 9 (37.50) | 18.2507 |
| 2000's | 10 (41.67) | 29.6817 |
| 2010's | 2 (8.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Candelaria, N; Lonard, DM; Nikolai, BC; O'Malley, BW; Padmanabhan, A; Richards, JS; Wong, KK | 1 |
| Armstrong, SR; Guo, B; Hembruff, SL; Kalatskaya, I; Lanner, C; Parissenti, AM; Reed, K; Sprowl, JA; Stein, L; Tam, A | 1 |
| Li, Y; Reddy, SA; Tsang, BK; Xiao, CW; Yan, X | 1 |
| Hall, JM; Korach, KS | 1 |
| Astancolle, S; Bettuzzi, S; Caporali, A; Marverti, G; Monti, MG; Moruzzi, MS | 1 |
| Casalini, P; Casati, B; Galmozzi, E; Iorio, MV; Ménard, S; Olgiati, C | 1 |
| Alberti, P; Bagnoli, M; Balladore, E; Canevari, S; Figini, M; Luison, E; Mazzoni, A; Mezzanzanica, D; Oggionni, M; Pilotti, S; Raspagliesi, F; Turatti, F | 1 |
| Ho, SM; Mukherjee, K; Syed, V | 1 |
| Burns, DJ; Langdon, SP; Macleod, KG; O'Donnell, AJ; Smyth, JF | 1 |
| Côté, M; Couture, MC; Grondin, R; Lane, D; Piché, A | 1 |
| Aiuchi, T; Ann, WW; Itabe, H; Nakajo, S; Nakaya, K; Sakairi, S; Shibayama-Imazu, T; Sonoda, I | 1 |
| Gorospe, M; Kawai, T; Otto, K; Rinker-Schaeffer, CW; Robinson, VL; Shalhav, O | 1 |
| Parry, EW | 1 |
| Broggini, M; Cattabeni, M; D'Incalci, M | 1 |
| Dahiya, R; Hughes-Fulford, M; Tjandrawinata, RR | 1 |
| Bostick-Bruton, F; Gardner, K; Li, Q; Reed, E; Tsang, B; Zhang, L | 2 |
| Chang, CL; Chen, WC; Huang, CF; Lee, SS; Su, Y | 1 |
| Cui, W; Pelling, JC; Persons, DL; Yazlovitskaya, EM | 1 |
| Chen, CA; Collins, JL; Herzog, TJ; Mutch, DG | 1 |
| Collins, JL; Kao, MS; Massad, LS; Mutch, DG; Powell, CB | 1 |
| Berek, J; Bonavida, B; Nio, Y; Zighelboim, J | 1 |
| Band, V; Karlan, BY; Littlefield, BA; Zurawski, VR | 1 |
| Böck, G; Dapunt, O; Daxenbichler, G; Fuith, LC; Marth, C | 1 |
24 other study(ies) available for cycloheximide and Cancer of Ovary
| Article | Year |
|---|---|
USP15-dependent lysosomal pathway controls p53-R175H turnover in ovarian cancer cells.
Topics: Cell Line, Tumor; Cycloheximide; Female; Gene Expression Regulation, Neoplastic; HEK293 Cells; Humans; Lysosomes; MCF-7 Cells; Mutation; Ovarian Neoplasms; Plasmids; Receptors, Steroid; Tumor Suppressor Protein p53; Ubiquitin-Specific Proteases | 2018 |
Alterations in tumor necrosis factor signaling pathways are associated with cytotoxicity and resistance to taxanes: a study in isogenic resistant tumor cells.
Topics: Antineoplastic Agents; Breast Neoplasms; Cell Survival; Cycloheximide; Docetaxel; Drug Resistance, Neoplasm; Female; Gene Expression Regulation, Neoplastic; Gene Regulatory Networks; Humans; MCF-7 Cells; NF-kappa B; Ovarian Neoplasms; Paclitaxel; Protein Synthesis Inhibitors; Proteolysis; Receptors, Tumor Necrosis Factor, Type I; Receptors, Tumor Necrosis Factor, Type II; Signal Transduction; Taxoids; Transcriptional Activation; Tumor Necrosis Factor-alpha | 2012 |
Resistance of human ovarian cancer cells to tumor necrosis factor alpha is a consequence of nuclear factor kappaB-mediated induction of Fas-associated death domain-like interleukin-1beta-converting enzyme-like inhibitory protein.
Topics: Antineoplastic Agents; Apoptosis; Carrier Proteins; CASP8 and FADD-Like Apoptosis Regulating Protein; Caspase 1; Caspase 3; Caspase 8; Caspase 9; Caspases; Cycloheximide; Drug Resistance, Neoplasm; Female; Gene Expression Regulation, Neoplastic; Humans; Intracellular Signaling Peptides and Proteins; NF-kappa B; Ovarian Neoplasms; Protein Structure, Tertiary; Protein Synthesis Inhibitors; Proteins; RNA, Messenger; Tumor Cells, Cultured; Tumor Necrosis Factor-alpha; X-Linked Inhibitor of Apoptosis Protein | 2003 |
Stromal cell-derived factor 1, a novel target of estrogen receptor action, mediates the mitogenic effects of estradiol in ovarian and breast cancer cells.
Topics: Breast Neoplasms; Carcinoma; Cell Division; Chemokine CXCL12; Chemokines, CXC; Cycloheximide; Estradiol; Estrogen Antagonists; Estrogen Receptor alpha; Female; Fulvestrant; Humans; Mitogens; Ovarian Neoplasms; Protein Isoforms; Protein Synthesis Inhibitors; Receptors, CXCR4; Receptors, Estrogen; RNA, Messenger; Tumor Cells, Cultured | 2003 |
Cisplatin-resistance modulates the effect of protein synthesis inhibitors on spermidine/spermine N(1)-acetyltransferase expression.
Topics: Acetyltransferases; Anisomycin; Antineoplastic Agents; Carcinoma; Cell Line, Tumor; Cisplatin; Cycloheximide; Dose-Response Relationship, Drug; Drug Resistance, Neoplasm; Drug Synergism; Female; Gene Expression Regulation, Neoplastic; Humans; Ovarian Neoplasms; Protein Synthesis Inhibitors; RNA, Messenger; Spermine | 2004 |
HER2 signaling enhances 5'UTR-mediated translation of c-Myc mRNA.
Topics: 5' Untranslated Regions; Androstadienes; Carcinoma; Cell Line, Tumor; Clone Cells; Cycloheximide; Dactinomycin; Enzyme Inhibitors; Female; Gene Expression Regulation, Neoplastic; Genes, erbB-2; Genes, myc; Genes, Reporter; Humans; Luciferases; Neuregulin-1; Ovarian Neoplasms; Phosphatidylinositol 3-Kinases; Promoter Regions, Genetic; Protein Biosynthesis; Protein Kinases; Protein Serine-Threonine Kinases; Protein Synthesis Inhibitors; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-akt; Proto-Oncogene Proteins c-myc; RNA, Messenger; Signal Transduction; TOR Serine-Threonine Kinases; Wortmannin | 2004 |
CD95-mediated apoptosis is impaired at receptor level by cellular FLICE-inhibitory protein (long form) in wild-type p53 human ovarian carcinoma.
Topics: Apoptosis; Blotting, Western; CASP8 and FADD-Like Apoptosis Regulating Protein; Caspase 8; Caspases; Cell Death; Cell Line, Tumor; Cycloheximide; Cytochromes c; DNA Fragmentation; Down-Regulation; Drug Resistance; Enzyme Activation; fas Receptor; Female; Flow Cytometry; Humans; Immunohistochemistry; Immunoprecipitation; Intracellular Signaling Peptides and Proteins; Lymphocytes; Mitochondria; Oligonucleotides, Antisense; Ovarian Neoplasms; Protein Synthesis Inhibitors; Subcellular Fractions; Time Factors; Transfection; Tumor Suppressor Protein p53 | 2004 |
Estrogen-induced loss of progesterone receptor expression in normal and malignant ovarian surface epithelial cells.
Topics: Adult; Apoptosis; Cells, Cultured; Cycloheximide; Dactinomycin; Down-Regulation; Epithelial Cells; Estrogens; Female; Humans; Middle Aged; Ovarian Neoplasms; Ovary; Progesterone; Receptors, Progesterone; Recombinant Fusion Proteins | 2005 |
Estrogen receptor-alpha mediates gene expression changes and growth response in ovarian cancer cells exposed to estrogen.
Topics: Cell Line, Tumor; Cell Proliferation; Cycloheximide; Dactinomycin; Estradiol; Estrogen Antagonists; Estrogen Receptor alpha; Estrogen Receptor beta; Estrogens; Female; Gene Expression; Gene Expression Regulation, Neoplastic; Humans; Oligonucleotide Array Sequence Analysis; Ovarian Neoplasms; Response Elements; RNA Stability; RNA, Messenger; Tamoxifen | 2005 |
Acquired resistance to TRAIL-induced apoptosis in human ovarian cancer cells is conferred by increased turnover of mature caspase-3.
Topics: Apoptosis; Apoptosis Regulatory Proteins; Caspase 3; Caspase 8; Caspase Inhibitors; Caspases; Cell Line, Tumor; Cycloheximide; Down-Regulation; Drug Resistance, Neoplasm; Female; Humans; Membrane Glycoproteins; Ovarian Neoplasms; Poly(ADP-ribose) Polymerases; Proteasome Inhibitors; Protein Synthesis Inhibitors; Receptors, Tumor Necrosis Factor; RNA Interference; RNA, Small Interfering; TNF-Related Apoptosis-Inducing Ligand; Tumor Necrosis Factor-alpha; X-Linked Inhibitor of Apoptosis Protein | 2006 |
Production of superoxide and dissipation of mitochondrial transmembrane potential by vitamin K2 trigger apoptosis in human ovarian cancer TYK-nu cells.
Topics: 1,2-Dihydroxybenzene-3,5-Disulfonic Acid Disodium Salt; Acetylcysteine; alpha-Tocopherol; Apoptosis; Cycloheximide; Diterpenes; Female; Humans; Membrane Potentials; Mitochondria; Ovarian Neoplasms; Reactive Oxygen Species; Superoxides; Tumor Cells, Cultured; Vitamin K 2 | 2006 |
Mitogen-activated protein kinase kinase 4/c-Jun NH2-terminal kinase kinase 1 protein expression is subject to translational regulation in prostate cancer cell lines.
Topics: Acetylcysteine; Blotting, Northern; Cell Line, Tumor; Cycloheximide; Dactinomycin; Ethanol; Female; Gene Expression Regulation, Enzymologic; Gene Expression Regulation, Neoplastic; Humans; Male; MAP Kinase Kinase 4; Neoplasm Metastasis; Ovarian Neoplasms; Polymerase Chain Reaction; Prostatic Neoplasms; Protein Biosynthesis | 2008 |
Cycloheximide challenge of mice bearing subcutaneous tumours, with observations on heparin treatment.
Topics: Animals; Carcinoma, Ehrlich Tumor; Cycloheximide; Female; Heparin; Male; Mice; Mice, Inbred CBA; Neoplasms, Experimental; Ovarian Neoplasms; Protein Biosynthesis; Skin Neoplasms | 1984 |
Differential expression of c-fos proto-oncogene in two subclones derived from a human ovarian cancer cell line.
Topics: Base Sequence; Cell Cycle; Cell Nucleus; Clone Cells; Culture Media; Cycloheximide; DNA Primers; Female; Gene Expression; Genes, fos; Humans; Immunoblotting; Kinetics; Molecular Sequence Data; Oligodeoxyribonucleotides; Ovarian Neoplasms; Polymerase Chain Reaction; Promoter Regions, Genetic; Proto-Oncogene Mas; Proto-Oncogenes; Restriction Mapping; RNA, Messenger; Tumor Cells, Cultured | 1995 |
Induction of cyclo-oxygenase-2 mRNA by prostaglandin E2 in human prostatic carcinoma cells.
Topics: 16,16-Dimethylprostaglandin E2; Anti-Ulcer Agents; Breast Neoplasms; Cell Count; Cell Division; Cycloheximide; Cyclooxygenase 2; DNA Replication; DNA, Neoplasm; Enzyme Induction; Female; Flurbiprofen; Humans; Isoenzymes; Male; Membrane Proteins; Ovarian Neoplasms; Prostaglandin-Endoperoxide Synthases; Prostatic Neoplasms; RNA, Messenger; Time Factors; Tumor Cells, Cultured | 1997 |
Cisplatin induction of ERCC-1 mRNA expression in A2780/CP70 human ovarian cancer cells.
Topics: Amanitins; Cisplatin; Cycloheximide; DNA Adducts; DNA-Binding Proteins; Endonucleases; Female; Gene Expression Regulation, Neoplastic; Half-Life; Humans; Ovarian Neoplasms; Protein Binding; Protein Biosynthesis; Proto-Oncogene Proteins c-fos; Proto-Oncogene Proteins c-jun; RNA, Messenger; Transcription Factor AP-1; Up-Regulation | 1998 |
In vitro cytotoxic activity of 1-decarboxy-3-oxo-ceanothic acid in a human ovarian adenocarcinoma cell line.
Topics: Adenocarcinoma; Antineoplastic Agents; Cell Survival; Cycloheximide; DNA Damage; DNA Fragmentation; DNA, Neoplasm; Female; Humans; Nucleosomes; Ovarian Neoplasms; Protein Synthesis Inhibitors; Triterpenes; Tumor Cells, Cultured | 1998 |
Phorbol ester exposure activates an AP-1-mediated increase in ERCC-1 messenger RNA expression in human ovarian tumor cells.
Topics: Amanitins; Binding Sites; Carcinogens; Cycloheximide; DNA Repair; DNA-Binding Proteins; Endonucleases; Female; Gene Expression Regulation, Neoplastic; Humans; Neoplasm Proteins; Nucleic Acid Synthesis Inhibitors; Ovarian Neoplasms; Protein Synthesis Inhibitors; Proteins; RNA, Messenger; RNA, Neoplasm; Tetradecanoylphorbol Acetate; Transcription Factor AP-1; Transcription, Genetic; Tumor Cells, Cultured | 1999 |
Cisplatin-induced activation of mitogen-activated protein kinases in ovarian carcinoma cells: inhibition of extracellular signal-regulated kinase activity increases sensitivity to cisplatin.
Topics: Adenocarcinoma; Antineoplastic Agents; Calcium-Calmodulin-Dependent Protein Kinases; Cisplatin; Cycloheximide; DNA Adducts; DNA Damage; DNA, Neoplasm; Enzyme Activation; Enzyme Induction; Enzyme Inhibitors; Female; Flavonoids; Gene Expression Regulation, Neoplastic; Humans; JNK Mitogen-Activated Protein Kinases; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; Mitogen-Activated Protein Kinases; Neoplasm Proteins; Ovarian Neoplasms; p38 Mitogen-Activated Protein Kinases; Protein Synthesis Inhibitors; Signal Transduction; Tumor Cells, Cultured | 1999 |
The effects of cyclosporin A on the lysis of ovarian cancer cells by cisplatin or adriamycin.
Topics: Antimetabolites, Antineoplastic; Buthionine Sulfoximine; Cell Death; Cisplatin; Cycloheximide; Cyclosporine; Doxorubicin; Drug Interactions; Drug Resistance; Emetine; Female; Humans; Methionine Sulfoximine; Ovarian Neoplasms; Tumor Cells, Cultured; Verapamil | 1992 |
Common expression of a tumor necrosis factor resistance mechanism among gynecological malignancies.
Topics: Antibodies, Neoplasm; Cell Survival; Cycloheximide; Dactinomycin; Dose-Response Relationship, Drug; Drug Resistance; Female; Humans; Immune Sera; Neoplasm Proteins; Ovarian Neoplasms; Time Factors; Tumor Cells, Cultured; Tumor Necrosis Factor-alpha; Uterine Cervical Neoplasms | 1990 |
Cycloheximide-induced modulation of TNF-mediated cytotoxicity in sensitive and resistant ovarian tumor cells.
Topics: Cell Survival; Cycloheximide; DNA, Neoplasm; Drug Interactions; Female; Humans; Ovarian Neoplasms; Protein Biosynthesis; Recombinant Proteins; RNA, Neoplasm; Time Factors; Tumor Cells, Cultured; Tumor Necrosis Factor-alpha | 1990 |
Simultaneous stimulation of urokinase and tissue-type plasminogen activators by phorbol esters in human ovarian carcinoma cells.
Topics: Cells, Cultured; Cycloheximide; Dactinomycin; Diglycerides; Enzyme-Linked Immunosorbent Assay; Female; Humans; Ovarian Neoplasms; Phorbol Esters; RNA, Messenger; Tetradecanoylphorbol Acetate; Tissue Plasminogen Activator; Urokinase-Type Plasminogen Activator | 1989 |
Modulation of ovarian carcinoma tumor marker CA-125 by gamma-interferon.
Topics: Antigens, Tumor-Associated, Carbohydrate; Cycloheximide; Dexamethasone; Female; HLA-DR Antigens; Humans; Interferon Type I; Interferon-gamma; Ovarian Neoplasms; Recombinant Proteins; Tumor Cells, Cultured | 1989 |